Profile
BCLI NVO VRTX REGN SGEN ARGX
Company Name Brainstorm Cell Therapeutics Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $13.00M $459.47B $102.31B $75.85B $43.15B $37.66B
Employees 0.03K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Chaim Lebovits Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
BCLI NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
BCLI NVO VRTX REGN SGEN ARGX
Last Close $2.28 $85 $397.27 $701.85 $228.74 $623.82
High 52 $3.25 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $0.22 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -29.85 % -42.14 % -23.12 % -41.6 % 0 % -2.27 %
Price vs. 52 Week Low 936.36 % 0 % 1.14 % 0 % 0 % 75.23 %
Total Return
BCLI NVO VRTX REGN SGEN ARGX
1 Month Return 83.87 % -17.18 % -11.79 % -5.73 % 0 % 4.54 %
3 Month Return 839.04 % -33.34 % -14.55 % -38.7 % 0 % 17.04 %
6 Month Return 516.22 % -40.12 % -15.24 % -33.36 % 0 % 58.14 %
9 Month Return 300 % -33.99 % -4.42 % -27.44 % 0 % 54.92 %
YTD Return 735.16 % -17.83 % -2.36 % -20.09 % 0 % 63.98 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCLI NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.68 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -6.73 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
BCLI NVO VRTX REGN SGEN ARGX
Asset Growth -50.21 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 7.02 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth 13.63 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth 27.56 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 62.62 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share 42.17 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share 12.32 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth 13.63 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -5.89 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 59.63 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG 23.16 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -26.08 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth 38.46 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 38.46 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -36.87 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -109.51 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share -145.06 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share -144.31 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth -83.58 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 99.89 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
BCLI NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM -39.57 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -702.62 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM 284.67 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM 263.16 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 106.91 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -9574.1 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM 3.48 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.04 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 9.53 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 6.86 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -2.13 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -2.13 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 3.16 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -8151.08 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -1.15 38.84 -87.91 22.46 -141.85 -178.29
Price To Operating Cash Flows Ratio TTM -1.07 22.2 -121.64 17.86 -203.89 -257.55
Price Cash Flow Ratio TTM -1.07 22.2 -121.64 17.86 -203.89 -257.55
Income Statement (TTM)
BCLI NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.02B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.4 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
BCLI NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.01B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $-0B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
BCLI NVO VRTX REGN SGEN ARGX
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.39
ABCL AbCellera Biologics Inc. 2.85
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.7
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.85
ABSI Absci Corporation 2.99
ABUS Arbutus Biopharma Corporation 3.21
ABVC ABVC BioPharma, Inc. 0.524
ABVX Abivax SA American Depositary Shares 7.65
ACAD ACADIA Pharmaceuticals Inc. 16.87
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9811
ACHV Achieve Life Sciences, Inc. 3.69
ACIU AC Immune SA 2.68
ACLX Arcellx, Inc. 75.54
ACRV Acrivon Therapeutics, Inc. Common Stock 6.71
ACST Acasti Pharma Inc. 3.37
ETFs With Exposure to BCLI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 293.28
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00006 129.79
VXF Vanguard Extended Market Index Fund 0 192.94
IWC iShares Micro-Cap ETF 0.00458 129.75
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.62
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.6
STSB iShares Factors US Small Blend Style ETF 0.02 24.7342
VTSAX Vanguard Total Stock Market Index Fund 0 142.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.27
VITSX Vanguard Total Stock Market Index Fund 0 142.71
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000106985 99.94
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.28
AVSC Avantis U.S. Small Cap Equity ETF 0 54.46
VEMPX Vanguard Extended Market Index InstlPlus 0 360.98
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 267.71
Unlock